Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Results available

AngioSafe Peripheral CTO Crossing System Study (RESTOR-1 Study)

ClinicalTrials.gov ID: NCT04663867

Public ClinicalTrials.gov record NCT04663867. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 12:34 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Safety and Effectiveness Study of the AngioSafe Peripheral CTO Crossing System

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study is designed to evaluate the safety and efficacy of the AngioSafe Peripheral CTO Crossing System.

Study identification

NCT ID
NCT04663867
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
AngioSafe, Inc.
Industry
Enrollment
79 participants

Conditions and interventions

Eligibility (public fields only)

Age range
22 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 3, 2021 (Actual)
Primary completion
Apr 25, 2023 (Actual)
Completion
Jun 15, 2023 (Actual)
Last update posted
Feb 12, 2026

2021 – 2023

United States locations

U.S. sites
18
U.S. states
14
U.S. cities
18
Facility City State ZIP Site status
Dignity Health - Chandler Regional Medical Center Chandler Arizona 85224 —
Adventist Health St. Helena St. Helena California 94754 —
Vascular Care Connecticut Darien Connecticut 06820 —
Palm Vascular Centers Miami Beach Florida 33140 —
Coastal Vascular & Interventional, PLLC Pensacola Florida 32504 —
Piedmont Heart Institute Atlanta Georgia 30309 —
Midwest Cardiovascular Research Foundation Davenport Iowa 52801 —
Cardiovascular Institute of the South Houma Louisiana 70360 —
Vascular Care Group Wellesley Massachusetts 06820 —
Saint Luke's Hospital of Kansas City Kansas City Missouri 64111 —
Mercy Hospital South St Louis Missouri 63128 —
American Endovascular & Amputation Prevention West Orange New Jersey 07052 —
Vascular Solutions of North Carolina Cary North Carolina 27518 —
The Miriam Hospital Providence Rhode Island 02906 —
Wellmont Cardiology Services Kingsport Tennessee 37660 —
VA North Texas Medical Center Dallas Texas 75216 —
Baylor Scott & White, The Heart Hospital Plano Plano Texas 75093 —
Cardiovascular Associated of East Texas Tyler Texas 75701 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04663867, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 12, 2026 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04663867 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →